Cue Biopharma, Inc. (CUE) has 54 open-market insider trades by 16 insiders since 2017. Over the last six months insiders net sold $2.4M. The most active filer is Christopher A. Marlett, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Aaron G.l. Fletcher | Dir | — | 4 | $4.7M | 2022-05-24 |
| Christopher A. Marlett | Dir | — | 12 | $2.8M | 2019-12-31 |
| Shao-Lee Lin | CEO | — | 2 | $1.9M | 2026-10-12 |
| Anish Suri | PresCSO | — | 6 | $886K | 2023-08-25 |
| Colin Sandercock | CLOVPSecretary | — | 4 | $767K | 2020-08-05 |
| Kenneth Pienta | — | — | 4 | $559K | 2021-03-16 |
| Anthony Digiandomenico | Dir | — | 5 | $426K | 2018-12-28 |
| Peter A. Kiener | Dir | — | 2 | $368K | 2023-03-23 |
| Sumita Ray | CLO | — | 1 | $266K | 2026-08-13 |
| Michael Vincent Meluzio | VP | — | 2 | $201K | 2026-10-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Vincent Meluzio | VP | Sell | $32K | 2026-10-12 |
| Shao-Lee Lin | CEO | Sell | $305K | 2026-10-12 |
| Sumita Ray | CLO | Sell | $52K | 2026-10-12 |
| Michael Vincent Meluzio | VP | Sell | $169K | 2026-08-13 |
| Sumita Ray | CLO | Sell | $266K | 2026-08-13 |
| Shao-Lee Lin | CEO | Sell | $1.6M | 2026-08-12 |
Companies that share insiders with CUE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Pasha Sarraf | Director | Buy | $100K | 2025-12-30 |
| Daniel R. Passeri | CEO | Buy | $31K | 2024-12-16 |
| Anish Suri | President | Buy | $11K | 2023-08-25 |
| Daniel R. Passeri | CEO | Buy | $9K | 2023-08-14 |
| Peter A. Kiener | Director | Sell | $31K | 2023-03-23 |
| Frank Morich | Director | Buy | $105K | 2022-05-27 |
| Aaron G.l. Fletcher | Director | Buy | $712K | 2022-05-23 |
| Aaron G.l. Fletcher | Director | Buy | $3.5M | 2022-03-31 |
| Peter A. Kiener | Director | Sell | $699K | 2021-11-15 |